Abstract:Infants born with congenital heart disease (CHD) may require emergent treatment in the newborn period. These infants are likely to benefit the most from a prenatal diagnosis, which allows for optimal perinatal planning. Several cardiac centers have created guidelines for the management of these high-risk patients with CHD. This paper will review and compare several prenatal CHD classification systems with a particular focus on the most critical forms of CHD in the fetus and newborn. A contemporary definition of critical CHD is one which requires urgent intervention in the first 24 h of life to prevent death. Such cardiac interventions may be not only life saving for the infant but also decrease subsequent morbidity. Critical CHD cases may require delivery at specialized centers that can provide perinatal, obstetric, cardiology and cardiothoracic surgery care. Fetuses diagnosed in mid-gestation require detailed fetal diagnostics and serial monitoring during the prenatal period, in order to assess for ongoing changes and identify progression to a more severe cardiac status. Critical CHD may progress in utero and there is still much to be learned about how to best predict those who will require urgent neonatal interventions. Despite improved therapeutic capabilities, newborns with critical CHD continue to have significant morbidity and mortality due to compromise that begins in the delivery room. Fetal echocardiography is the best way to predict the need for specialized care at birth to improve outcome. Once the diagnosis is made of critical CHD, delivery at the proper time and in appropriate institution with specific care protocols should be initiated. More work needs to be done to better delineate the risk factors for progression of critical CHD and to determine which newborns will require specialized care. The most frequently described forms of critical CHD requiring immediate intervention include hypoplastic left heart syndrome with intact or severely restricted atrial septum, obstructed total anomalous pulmonary venous return and transposition of the great arteries with restrictive atrial septum.

ADVANCES IN DIAGNOSIS AND TREATMENT OF CONGENITAL HEART DISEASE: A COMPREHENSIVE REVIEW

The Progress and Challenges of Surgical Treatment for Congenital Heart Disease

Congenital heart disease: types, pathophysiology, diagnosis, and treatment options

Pediatric Heart Surgery in China: Progress and Challenges

The Current Strategy in Managing Congenital and Structural Heart Disease: Find and Treat Them Appropriately

Challenges in the Diagnosis of Adult Congenital Heart Diseases

Recent Advances in the Diagnosis and Management of Congenital Heart Disease

[Research Progress on Genetic and Epigenetic Mechanisms in Congenital Heart Disease].

Echocardiography in Simple Congenital Heart Diseases: Guiding Adult Patient Management

The mechanics of congenital heart disease: from a morphological trait to the functional echocardiographic evaluation

Advance in Surgery of Congenital Heart Disease

Application of 3 D Printing Techniques in Treatment of Congenital Heart Disease

Screening for Congenital Heart Defects: Diversified Strategies in Current China

[Specification for Genetic Diagnosis of Congenital Heart Disease].

Percutaneous closure of simple congenital heart diseases under echocardiographic guidance

Advances in Pediatric Cardiology in 2019: a Narrative Review

Progresses in Genetic Testing in Congenital Heart Disease

Fetal cardiology: changing the definition of critical heart disease in the newborn

Advance in Imaging Diagnosis of Congenital Heart Disease

Transforming congenital heart disease management: Advances in fetal cardiac interventions

Advancement in Research on Genes Associated with Fetal Congenital Heart Disease(chd)and Diagnostic Testing Methods